Financière de Tubize S.A.

TUB

BE0003823409

Pharmaceuticals

Market Closed - Euronext Bruxelles Other stock markets 11:35:10 2024-04-26 am EDT			5-day change	1st Jan Change
94.6 ^EUR	+1.83%		+2.94%	+31.94%

Mar. 27	Financière de Tubize SA Announces Board Resignations	CI
Mar. 16	Financière de Tubize SA Proposes Gross Dividend, Payable on 3 May 2024	CI

Financière de Tubize SA Reports Earnings Results for the Full Year Ended December 31, 2019

February 20, 2020 at 09:50 am EST

Financière de Tubize SA announced earnings results for the full year ended December 31, 2019. For the full year, the company announced net income was EUR 283.704 million compared to EUR 285.156 million a year ago. Basic earnings per share was EUR 6.37 compared to EUR 6.4 a year ago.

Latest news about Financière de Tubize S.A.

Financière de Tubize SA Announces Board Resignations	Mar. 27	CI
Financière de Tubize SA Proposes Gross Dividend, Payable on 3 May 2024	Mar. 16	CI
Financière de Tubize SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
Financière de Tubize SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-29	CI
Financière de Tubize SA Announces Dividend Approval, Payable as from 5 May 2023	23-04-29	CI
Financière de Tubize SA's Equity Buyback announced on December 1, 2018, has expired.	23-04-23	CI
Financière de Tubize SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-18	CI
Financière De Tubize SA Proposes Dividend, Payable on 5 May 2023	23-02-25	CI
Financière de Tubize SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-28	CI
Financière de Tubize SA Approves Distribution of Gross Dividend for the Year Ended December 31, 2021, Payable on 5 May 2022	22-04-29	CI
Financière de Tubize SA to Consider the Resignation of Edouard Janssenas as Director	22-03-24	CI
Financière De Tubize Sa Proposes Dividend for 2021, Payable on 5 May 2022	22-03-01	CI
Financière de Tubize SA Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-26	CI
Financière De Tubize Sa Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-02	CI
Financière de Tubize SA Approves Dividend, Payable on May 6, 2021	21-04-30	CI
Financière de Tubize SA Proposes Dividend, Payable on 6 May 2021	21-02-27	CI
Financière De Tubize Sa Reports Earnings Results for the Half Year Ended June 30, 2020	20-07-27	CI
Tranche Update on Financière de Tubize SA's Equity Buyback Plan announced on December 1, 2018.	20-07-23	CI
Financière de Tubize SA Reports Earnings Results for the Full Year Ended December 31, 2019	20-02-20	CI
Financière De Tubize Sa Announces Board Changes; Proposes Dividend Payable on 8 May 2020	20-02-20	CI
Tranche Update on Financière de Tubize SA's Equity Buyback Plan announced on December 1, 2018.	20-02-19	CI
Financière De Tubize Sa Reports Earnings Results for the Half Year Ended June 30, 2019	19-07-25	CI
Tranche Update on Financière de Tubize SA's Equity Buyback Plan announced on December 1, 2018.	19-07-24	CI
Financière de Tubize SA Approves Dividend for the Year 2018, Payable on May 6, 2019	19-04-25	CI
Financifre De Tubize Sa Reports Earnings Results for the Full Year Ended December 31, 2018	19-02-28	CI

Chart Financière de Tubize S.A.

Duration

Period

More charts

Company Profile

Financière de Tubize S.A. is a holding company that owns 36.24% of the listed biopharmacy group UCB.

Sector

Pharmaceuticals

Calendar

2024-07-24 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

94.6 EUR

Average target price

118.2 EUR

Spread / Average Target

+25.00%

Consensus

Sector Other Pharmaceuticals

	1st Jan change	Capi.
FINANCIÈRE DE TUBIZE S.A.	+31.94%	4.5B
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals